Transdermal Drug Delivery Market Report

Japan Transdermal Drug Delivery Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 17, 2019
  • PAGES：145
  • REPORT CODE：GMM291428
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Transdermal Drug Delivery market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Transdermal Drug Delivery market. Detailed analysis of key players, along with key growth strategies adopted by Transdermal Drug Delivery industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • GlaxoSmithKline

    • Bayer

    • Actelion

    • Actavis

    • Mylan Pharmaceuticals

    • Novartis


    By Type:

    • Electric current

    • Mechanical arrays

    • Thermal Ablation

    • Chemical Enhancers

    • Others


    By End-User:

    • Cardiovascular

    • CNS

    • Pain Management

    • Dermatology

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transdermal Drug Delivery Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Transdermal Drug Delivery Market Size and Growth Rate of Electric current from 2014 to 2026

      • 1.3.2 Japan Transdermal Drug Delivery Market Size and Growth Rate of Mechanical arrays from 2014 to 2026

      • 1.3.3 Japan Transdermal Drug Delivery Market Size and Growth Rate of Thermal Ablation from 2014 to 2026

      • 1.3.4 Japan Transdermal Drug Delivery Market Size and Growth Rate of Chemical Enhancers from 2014 to 2026

      • 1.3.5 Japan Transdermal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Transdermal Drug Delivery Market Size and Growth Rate of Cardiovascular from 2014 to 2026

      • 1.4.2 Japan Transdermal Drug Delivery Market Size and Growth Rate of CNS from 2014 to 2026

      • 1.4.3 Japan Transdermal Drug Delivery Market Size and Growth Rate of Pain Management from 2014 to 2026

      • 1.4.4 Japan Transdermal Drug Delivery Market Size and Growth Rate of Dermatology from 2014 to 2026

      • 1.4.5 Japan Transdermal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Transdermal Drug Delivery Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transdermal Drug Delivery by Major Types

      • 3.4.1 Market Size and Growth Rate of Electric current

      • 3.4.2 Market Size and Growth Rate of Mechanical arrays

      • 3.4.3 Market Size and Growth Rate of Thermal Ablation

      • 3.4.4 Market Size and Growth Rate of Chemical Enhancers

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Transdermal Drug Delivery Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transdermal Drug Delivery by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transdermal Drug Delivery in Cardiovascular

      • 4.4.2 Market Size and Growth Rate of Transdermal Drug Delivery in CNS

      • 4.4.3 Market Size and Growth Rate of Transdermal Drug Delivery in Pain Management

      • 4.4.4 Market Size and Growth Rate of Transdermal Drug Delivery in Dermatology

      • 4.4.5 Market Size and Growth Rate of Transdermal Drug Delivery in Others


    5 Market Analysis by Regions

    • 5.1 Japan Transdermal Drug Delivery Production Analysis by Regions

    • 5.2 Japan Transdermal Drug Delivery Consumption Analysis by Regions


    6 Hokkaido Transdermal Drug Delivery Landscape Analysis

    • 6.1 Hokkaido Transdermal Drug Delivery Landscape Analysis by Major Types

    • 6.2 Hokkaido Transdermal Drug Delivery Landscape Analysis by Major End-Users


    7 Tohoku Transdermal Drug Delivery Landscape Analysis

    • 7.1 Tohoku Transdermal Drug Delivery Landscape Analysis by Major Types

    • 7.2 Tohoku Transdermal Drug Delivery Landscape Analysis by Major End-Users


    8 Kanto Transdermal Drug Delivery Landscape Analysis

    • 8.1 Kanto Transdermal Drug Delivery Landscape Analysis by Major Types

    • 8.2 Kanto Transdermal Drug Delivery Landscape Analysis by Major End-Users


    9 Chubu Transdermal Drug Delivery Landscape Analysis

    • 9.1 Chubu Transdermal Drug Delivery Landscape Analysis by Major Types

    • 9.2 Chubu Transdermal Drug Delivery Landscape Analysis by Major End-Users


    10 Kinki Transdermal Drug Delivery Landscape Analysis

    • 10.1 Kinki Transdermal Drug Delivery Landscape Analysis by Major Types

    • 10.2 Kinki Transdermal Drug Delivery Landscape Analysis by Major End-Users


    11 Chugoku Transdermal Drug Delivery Landscape Analysis

    • 11.1 Chugoku Transdermal Drug Delivery Landscape Analysis by Major Types

    • 11.2 Chugoku Transdermal Drug Delivery Landscape Analysis by Major End-Users


    12 Shikoku Transdermal Drug Delivery Landscape Analysis

    • 12.1 Shikoku Transdermal Drug Delivery Landscape Analysis by Major Types

    • 12.2 Shikoku Transdermal Drug Delivery Landscape Analysis by Major End-Users


    13 Kyushu Transdermal Drug Delivery Landscape Analysis

    • 13.1 Kyushu Transdermal Drug Delivery Landscape Analysis by Major Types

    • 13.2 Kyushu Transdermal Drug Delivery Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Bayer

      • 14.2.1 Bayer Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Actelion

      • 14.3.1 Actelion Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Actavis

      • 14.4.1 Actavis Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Mylan Pharmaceuticals

      • 14.5.1 Mylan Pharmaceuticals Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Novartis

      • 14.6.1 Novartis Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 92 Figures and 120 Tables)

     

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Electric current from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Mechanical arrays from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Thermal Ablation from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Chemical Enhancers from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of CNS from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Pain Management from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Dermatology from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Transdermal Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Transdermal Drug Delivery Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Transdermal Drug Delivery

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transdermal Drug Delivery by Different Types from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Delivery by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Electric current

    • Figure Market Size and Growth Rate of Mechanical arrays

    • Figure Market Size and Growth Rate of Thermal Ablation

    • Figure Market Size and Growth Rate of Chemical Enhancers

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Transdermal Drug Delivery by Different End-Users from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Delivery by Different End-Users from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of CNS from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Pain Management from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Dermatology from 2014 to 2026

    • Figure Japan Transdermal Drug Delivery Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Transdermal Drug Delivery Production by Regions

    • Table Japan Transdermal Drug Delivery Production Share by Regions

    • Figure Japan Transdermal Drug Delivery Production Share by Regions in 2014

    • Figure Japan Transdermal Drug Delivery Production Share by Regions in 2018

    • Figure Japan Transdermal Drug Delivery Production Share by Regions in 2026

    • Table Japan Transdermal Drug Delivery Consumption by Regions

    • Table Japan Transdermal Drug Delivery Consumption Share by Regions

    • Figure Japan Transdermal Drug Delivery Consumption Share by Regions in 2014

    • Figure Japan Transdermal Drug Delivery Consumption Share by Regions in 2018

    • Figure Japan Transdermal Drug Delivery Consumption Share by Regions in 2026

    • Table Hokkaido Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Hokkaido Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Hokkaido Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Hokkaido Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Tohoku Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Tohoku Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Tohoku Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Tohoku Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Tohoku Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Kanto Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kanto Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kanto Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Kanto Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Kanto Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Kanto Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kanto Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kanto Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kanto Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Chubu Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chubu Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chubu Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Chubu Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Chubu Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Chubu Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chubu Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chubu Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chubu Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Kinki Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kinki Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kinki Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Kinki Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Kinki Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Kinki Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kinki Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kinki Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kinki Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Chugoku Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chugoku Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Chugoku Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chugoku Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chugoku Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Shikoku Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Shikoku Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Shikoku Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Shikoku Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Shikoku Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Kyushu Transdermal Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kyushu Transdermal Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by Types in 2014

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by Types in 2018

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by Types in 2026

    • Table Kyushu Transdermal Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kyushu Transdermal Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kyushu Transdermal Drug Delivery Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Actelion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actelion

    • Figure Sales and Growth Rate Analysis of Actelion

    • Figure Revenue and Market Share Analysis of Actelion

    • Table Product and Service Introduction of Actelion

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Mylan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals

    • Table Product and Service Introduction of Mylan Pharmaceuticals

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US